The legacy of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, yielding billions in income, its intellectual property lapse created a wave of generic competition , significantly eroding its market share . While certain businesses may seek to capitalize on related treatments , the curr